Brief: GT Biopharma Announces $6.5 Million Registered Direct Offering Priced At Premium To Market

GT Biopharma

30/12/2022 15:09

Dec 30 (Reuters) - GT Biopharma Inc  GTBP.O :
    * GT BIOPHARMA, INC. ANNOUNCES $6.5 MILLION REGISTERED
DIRECT
OFFERING PRICED AT PREMIUM TO MARKET
    * GT BIOPHARMA, INC. ANNOUNCES $6.5 MILLION REGISTERED
DIRECT
OFFERING PRICED AT PREMIUM TO MARKET
    * GT BIOPHARMA - COMBINED PURCHASE PRICE OF $1.00 PER SHARE
OF
COMMON STOCK AND ASSOCIATED WARRANT IN A REGISTERED DIRECT
OFFERING

Source text for Eikon:  ID:nGNX4DCZWT 
Further company coverage:  GTBP.O